US Patent 10463686 Immune modulation with TLR9 agonists for cancer treatment
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+185 characters)
Article
Patent abstract
The present invention relates to methods for treating a tumor, including a metastatic tumor, with TLR9 agonist in combination with an immune checkpoint inhibitor therapy.
Edits on 3 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Daqing Wang0
Sudhir Agrawal0
Wayne Jiang0
Edits on 10 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
104636860
Date of Patent
November 5, 2019
0Patent Application Number
157056310
Date Filed
September 15, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 7 Sep, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 29 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 10463686 Immune modulation with TLR9 agonists for cancer treatment
Infobox
Is a
Patent applicant
Patent jurisdiction
Patent number
10463686
Date of patent
November 5, 2019
Patent application number
15705631
Date Filed
September 15, 2017
Patent primary examiner
Find more entities like US Patent 10463686 Immune modulation with TLR9 agonists for cancer treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
